相关实验视频

Updated: Jul 10, 2025

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

恶性胆道阻塞的初始管理ERCP - 596个程序的现实世界数据

I M Mikalsen¹, S Breder^2,3, A W Medhus^1,3

¹Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.

Scandinavian journal of gastroenterology

|November 23, 2023

概括

内镜逆行胆血管细胞造影 (ERCP) 有效地管理恶性胆道阻塞 (MBO),在62%的患者中达到50%的胆红素降低. 这项研究证实ERCP是MBO的有效一线治疗选择.

科学领域:

胃肠病学胃肠病学
干预性内镜检查是干预性的内镜检查.
在瘤学瘤学.

背景情况:

恶性胆道阻塞 (MBO) 在患者管理中带来了重大挑战.
有效的MBO第一线治疗策略对于改善患者的治疗结果至关重要.

研究的目的:

评估内镜逆行胆管瘤学 (ERCP) 作为恶性胆道阻塞 (MBO) 患者的初始治疗策略的现实结果.

主要方法:

一项回顾性观察性研究包括2015年至2021年期间为MBO接受ERCP的596名患者.
主要结局是ERCP后30天内胆红素减少≥50%.
二次结果包括技术成功,并发症和整体死亡率.

主要成果:

62%的患者实现了主要结局 (bilirubin 降低).
总体而言,技术成功率为80%,根据阻塞位置的变化 (例如,偏远外肝MBO的85%).
15%的患者出现并发症,90天死亡率为33%.

结论:

ERCP显示出高临床疗效和技术成功,特别是在远端外肝和周围膜MBO.
ERCP是恶性胆道阻塞的第一线管理的可行和有效的选择.

关键词:

内镜逆行胆血管细胞造影 (ERCP) 是一种内镜逆行胆血管细胞造影.胆瘤是一种胆瘤.恶性胆道阻塞 (MBO) 是一种恶性胆道阻塞.胰腺癌是一种癌症.在ERCP后的并发症.在ERCP后的胰腺炎.技术上的成功技术上的成功

更多相关视频

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Published on: February 10, 2023

相关概念视频

Endoscopic Procedures V: ERCP

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...